Helix BioPharma HBPCF Stock
Helix BioPharma Price Chart
Helix BioPharma HBPCF Financial and Trading Overview
| Helix BioPharma stock price | 0.45 USD |
| Previous Close | 0.15 USD |
| Open | 0.15 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.15 - 0.15 USD |
| 52 Week Range | 0.14 - 0.16 USD |
| Volume | 1K USD |
| Avg. Volume | 64 USD |
| Market Cap | 31.42M USD |
| Beta (5Y Monthly) | -0.62 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.73 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
HBPCF Valuation Measures
| Enterprise Value | 30.61M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -4.849 |
Trading Information
Helix BioPharma Stock Price History
| Beta (5Y Monthly) | -0.62 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 0.16 USD |
| 52 Week Low | 0.14 USD |
| 50-Day Moving Average | 0.14 USD |
| 200-Day Moving Average | 0.14 USD |
HBPCF Share Statistics
| Avg. Volume (3 month) | 64 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 216.67M |
| Float | 177.45M |
| Short Ratio | 3.83 |
| % Held by Insiders | 18.41% |
| % Held by Institutions | 12.16% |
| Shares Short | 2.27K |
| Short % of Float | 0% |
| Short % of Shares Outstanding | 0% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | July 31, 2023 |
| Most Recent Quarter (mrq) | July 31, 2023 |
| Next Fiscal Year End | July 31, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -166.12% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -6313000 USD |
| Net Income Avi to Common (ttm) | -6290000 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 808K USD |
| Total Cash Per Share (mrq) | 0.004 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.531 |
| Book Value Per Share (mrq) | -0.004 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5527000 USD |
| Levered Free Cash Flow (ttm) | -2203500 USD |
Profile of Helix BioPharma
| Country | United States |
| State | ON |
| City | Toronto |
| Address | 401 Bay Street |
| ZIP | M5H 2Y4 |
| Phone | 905-841-2300 |
| Website | https://www.helixbiopharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 9 |
Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with University Hospital Tuebingen to assess the therapeutic response of L-DOS47 in cancer models expressing CEACAM6, with advanced preclinical metabolic imaging. The company is headquartered in Toronto, Canada.
Q&A For Helix BioPharma Stock
What is a current HBPCF stock price?
Helix BioPharma HBPCF stock price today per share is 0.45 USD.
How to purchase Helix BioPharma stock?
You can buy HBPCF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Helix BioPharma?
The stock symbol or ticker of Helix BioPharma is HBPCF.
Which industry does the Helix BioPharma company belong to?
The Helix BioPharma industry is Biotechnology.
How many shares does Helix BioPharma have in circulation?
The max supply of Helix BioPharma shares is 63.41M.
What is Helix BioPharma Price to Earnings Ratio (PE Ratio)?
Helix BioPharma PE Ratio is now.
What was Helix BioPharma earnings per share over the trailing 12 months (TTM)?
Helix BioPharma EPS is -0.73 USD over the trailing 12 months.
Which sector does the Helix BioPharma company belong to?
The Helix BioPharma sector is Healthcare.